How This CRISPR Biotech Could Make Investors Rich Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a biotech company that represents a solid trend in the industry. Source: BioSpace You Might Also Like Unwanted Light Shines on AstraZeneca and Its Blockbuster Seroquel December 6, 2017 MolecularMD Announces Partnership With To Support Improved Clinical Trial Histopathology Workflows Integrating Digital Biomarker Analysis Services September 28, 2017 KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
MolecularMD Announces Partnership With To Support Improved Clinical Trial Histopathology Workflows Integrating Digital Biomarker Analysis Services September 28, 2017
KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018